4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-17-001018
CIK 0001572552operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:15 PM ET
Size
8.0 KB
Accession
0001140361-17-001018
Insider Transaction Report
Form 4
Spink Katharine E.
Vice President & COO
Transactions
- Exercise/Conversion
Common Stock
2016-12-27$2.34/sh+2,500$5,850→ 2,500 total - Exercise/Conversion
Options to Purchase Common Stock
2016-12-27+2,500→ 192,500 totalExercise: $2.34From: 2013-03-10Exp: 2020-03-09→ Common Stock (2,500 underlying) - Sale
Common Stock
2016-12-27$5.00/sh−2,500$12,500→ 0 total
Footnotes (2)
- [F1]The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
- [F2]Excludes 7,658 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:15 PM ET
- Size
- 8.0 KB